This project aims towards an integrated microfluidic lab-on-a-chip platform for fast, reliable, contamination free, sensitive and economic diagnostics of tuberculosis, including genetic detection of resistance to antituberculous drugs.
To achieve this goal, biochemical processes are integrated into a centrifugal microfluidic cartridge that enables automated detection of the pathogen and of resistance to anti-tuberculous drugs in standard laboratory devices (centrifuge, PCR cycler). Hence, such diagnostic tests can be performed by non-experts using inexpensive laboratory equipment, in particular in poorly developed regions with a high prevalence of tuberculosis.back to overview
|Promoter:||VDI Technologiezenturm GmbH|
|Duration:||01.05.2015 to 30.09.2018|
|Cooperation Partner:||Robert Bosch GmbH, Hain-Lifescience GmbH, Gerbion GmbH, Braunform GmbH, IML Red GmbH|